Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VTR vs GSK✓SelectedUSD · GSKVTR vs GSK performance historyLatest closeAs of-0.04%11/16
Stock and ETF performance explorer

VTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+122.5%
GSK return
+107.3%
Excess return
+15.3%
Maximum drawdown
-76.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%-0.1%0.0%0.0%
7D-0.7%-1.3%+0.6%-0.1%
30D+3.5%+2.7%+0.8%+2.3%
3M-2.3%+2.7%-5.0%-3.7%
6M+2.8%+3.3%-0.5%+1.0%
YTD+17.0%+6.5%+10.5%+12.5%
1Y+16.8%+10.7%+6.1%+10.2%
3Y+117.5%+64.4%+53.2%+63.8%
5Y+94.2%+46.7%+47.5%+51.1%
10Y+122.5%+109.4%+13.2%+52.7%
All+122.5%+107.3%+15.3%+52.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling